Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 8848188.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fifteen percent of multiple sclerosis patients about to be treated with interferon beta-1b exhibited elevated numbers of circulating interferon-gamma-secreting cells, defined as a value that exceeded the mean value for healthy controls by more than two standard deviations. Sixty percent of patients receiving the drug exhibited elevated interferon-gamma-secreting cell numbers during their first 2 months of treatment. Values normalized after 3 months. Prednisone treatment during the first month on the drug prevented the interferon-gamma-secreting cell surge.
Medical subject headings
- Blood Cells
- Interferon-beta
- Interferon-gamma
- Multiple Sclerosis